|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4-Aminodiphenyl |
CAS 92-67-1 | ||
C6H5C6H4NH2 |
RTECS DU8925000 | ||
|
Synonyms & Trade Names 4-Aminobiphenyl, p-Aminobiphenyl, p-Aminodiphenyl, 4-Phenylaniline |
DOT ID & Guide |
||
Exposure
|
NIOSH REL: Ca See Appendix A | ||
| OSHA PEL: [1910.1011] See Appendix B | |||
| IDLH Ca [N.D.] See: IDLH INDEX | Conversion | ||
|
Physical Description Colorless crystals with a floral odor. [Note: Turns purple on contact with air.] |
|||
|
MW: 169.2 |
BP: 576°F |
MLT: 127°F |
Sol: Slight |
|
VP(227°F): 1 mmHg |
IP: ? |
|
Sp.Gr: 1.16 |
|
Fl.P: ? |
UEL: ? |
LEL: ? |
|
| Combustible Solid, but must be preheated before ignition possible. | |||
|
Incompatibilities & Reactivities Oxidized by air |
|||
|
Measurement Methods NIOSH P&CAM269 (II-4); OSHA 93 See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Important additional information about respirator selection Respirator Recommendations (See Appendix E) NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator with an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Headache, dizziness; drowsiness, dyspnea (breathing difficulty); ataxia, lassitude (weakness, exhaustion); methemoglobinemia; urinary burning; acute hemorrhagic cystitis; [potential occupational carcinogen] | |
|
Target Organs
Bladder, skin Cancer Site [bladder cancer] |
|
| See also: INTRODUCTION See ICSC CARD: 0759 See MEDICAL TESTS: 0012 |